From memory the mayo trial used subjective measures of accuracy compared to the JHC trial which compared current standard to the Herabeat at the heart race trace level.
the result of the usability scale were both subjective so that was a disappointing finding. However I wonder if the score would be higher if the full benefit/integration of the platform was considered. Its not quite apple to apples if the standard doppler cant integrate with a broader platform which as we have long been saying is the main play here; the doppler being somewhat of a side show.
When i read the result some time back i didnt think the mayo trial wasnt particularly well thought out and designed. In regards to management being quiet, maybe they feel the same and wouldnt come out and say as such.
Why no news from joondalup and us?, page-18
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add HMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.1¢ |
Change
-0.002(8.70%) |
Mkt cap ! $13.29M | |||
| Open | High | Low | Value | Volume |
| 2.3¢ | 2.3¢ | 2.1¢ | $14.34K | 644.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1079500 | 2.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.4¢ | 200000 | 1 |
View Market Depth
| Last trade - 13.36pm 12/09/2024 (20 minute delay) ? |
| HMD (ASX) Chart |